ARCHIVES

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

This article is from The Cancer Letter archive.

Vol. 24 No. 47 | December 11, 1998

Download PDF Visit The Full Archive

Related Articles

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011